Goodwin

Felipe M. Heiderich

Deals
3
Latest
May 2026
Most deals in
Biotech

Firm

  • Goodwin Law firm · 2026 · 3 deals
Deals by year
Felipe M. Heiderich: deals by year0320252026 YTD: 3 M&A32026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Felipe M. Heiderich was named on, most recent first
May 2026 LimmaTech Biologics AG –Eli Lilly and CompanyAcquisitionLegal adviser to LimmaTech Biologics AG (target)Pending780.0BiotechEli Lilly and Company acquisition of LimmaTech Biologics AG
Mar 2026 Ouro Medicines –GileadAcquisitionLegal adviser to Ouro Medicines (target)Announced1,675.0Biotech+1Gilead acquisition of Ouro Medicines
Feb 2026 Orna Therapeutics –Eli Lilly and CompanyAcquisitionLegal adviser to Orna Therapeutics (target)Announced2,400.0Biotech+1Eli Lilly and Company acquisition of Orna Therapeutics

Deals where Felipe M. Heiderich is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.